King of Prussia, PA 11/29/18—LC provider Tosoh Bioscience announced that it plans to acquire Semba Biosciences following an equity investment in the company. Semba Biosciences develops and sells multicolumn continuous chromatography systems for the purification of biomolecules. “By combining Semba Biosciences’ advanced Simulated Moving Bed (SMB) technology with Tosoh Bioscience’s best-in-class resins, we will be able to offer the most productive and the most efficient solution in bioprocess chromatography while maintaining the highest quality,” stated Ali Soleymannezhad, director of Sales and Marketing at Tosoh Bioscience. The companies have collaborated since 2007.

Tosoh Bioscience provides columns and resins that can be used with Semba Biosciences’ SMB systems. This will be Tosoh Bioscience’s first hardware offering for the bioprocess market.